Subjects: PDT, TDS, PLW, FVT
Tyber Medical Announces the Patent Allowance of TyFixtm, An All-in-One Extremity System
BETHLEHEM, Pa., July 11, 2018 /PRNewswire/ -- Tyber Medical, LLC, a privately held company focusing on developing innovative medical devices for rapid commercialization and advancing the science of bioengineered surfaces, announces the allowance for US Patent Application (No. 15/213,935) of TyFixtm, an all-in-one extremity joint fixation system.
The TyFixtm sterile system delivers increased operating room efficiency and serial procedural flow by combining an intramedullary implant to the driver, drill, and broach instruments. The all-in-one instrument/implant design, combined with the recently released Sterile Handle Kit, is designed to reduce procedure steps and total operative time, while delivering an implant construct capable of maintaining the holding power of a 3.0 Screw.
"The notice of allowance granted to Tyber Medical highlights the Company's growing strategy of building innovative products backed by science and intellectual property," commented Jeff Tyber, CEO and President of Tyber Medical. Mr. Tyber added, "Tyber Medical recently targeted the Ambulatory Surgical Center (ASC) market with the limited release of the Forefoot Procedure Kit. The resultant patent family aims to be the foundation for future system solutions that enhances the economic value to both hospitals and ASC's by eliminating redundant processing costs, simplifying instrumentation, and increasing the operating room cadence through instrumentation integration."
The TyFixtm Patent is the eighth patent issued to the Company with an additional 10 patents pending for approval. Joseph Maenner, J.D., Tyber Medical Intellectual Property Counsel commented, "Tyber Medical's patent strategy is centered around building innovation platforms backed by intellectual property. These platforms can be combined or rearranged to meet multiple products and customers needs. Additionally, the breadth of these IP fillings locks innovative design dates and allows the patent families to morph as product systems are developed or block competitive entry to the market."
The TyFixtm system received FDA clearance in July 2017 for the innovative system that reduces the need for ancillary instrumentation for a wide range of bone fixation procedures. The TyFixtm combines a highly-optimized bone thread with a barbed head to maximize intramedullary bone purchase and compression in both the proximal and distal phalanges. The system delivers intraoperative flexibility by offering solid and cannulated implants with diameters ranging from Ø1.5 - 4.0mm in multiple lengths as well as a straight and an angled 10o option.
Visit Tyber Medical's Booth #627, at AOFAS in Boston, MA where the Company will showcase the TyFixtm System as well as other innovative products available for private labeling.
About Tyber Medical, LLC.
Tyber Medical, LLC is an orthopedic device manufacturer providing rapid access to portfolio enhancing, regulatory approved, orthopedic implants within the spine and extremity/trauma markets. While focusing on rapid product commercialization, the Company distributes products via private labeling; releasing 14 spine and 25 extremity/trauma systems since its founding in 2012. Tyber Medical utilizes the differentiated, bioengineered technology such as TyPEEK® osteoconductive coatings and BioTytm, a new antimicrobial nano-textured surface modification to enhance the Company's growing portfolio.
Contact:
Eric Dickson
83 South Commerce Way, Suite 310
Bethlehem PA 18017
(610) 849-1710
[email protected]
SOURCE Tyber Medical, LLC
These press releases may also interest you
|
News published on and distributed by:
